|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:552-561
© 2004 The American Association for Thoracic Surgery
Surgery for acquired cardiovascular disease |
a Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
b Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
c Cardiac, Thoracic and Vascular Surgery, Inc, St Louis, Mo, USA
d Cardiac Surgery Department, The Children's Hospital, University of Colorado Health Sciences Center, Denver, Colo, USA
e Department of Cardiovascular Surgery, Children's Hospital, Harvard Medical School, Boston, Mass, USA
f Harvard-MIT Division of Health Sciences and Technology (HST), Harvard Medical School, Boston, Mass, USA
Received for publication November 20, 2003; revisions received March 22, 2004; accepted for publication April 19, 2004.
* Address for reprints: Frederick J. Schoen, MD, PhD, Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA
fschoen{at}partners.org
OBJECTIVE: We studied the pathologic features, cellular phenotypes, and matrix remodeling of clinical pulmonary-to-aortic valve transplants functioning up to 6 years.
METHODS: Nine autografts and associated vascular walls early (2-10 weeks) and late (3-6 years) postoperatively were examined by using routine morphologic methods and immunohistochemistry. In 4 cases autograft and homograft cusps were obtained from the same patients.
RESULTS: Autografts had near-normal trilaminar cuspal structure and collagen architecture and viable valvular interstitial and endothelial cells throughout the time course. In contrast, cusps of homografts used to replace the pulmonary valves in the same patients were devitalized. In early autograft explants, 19.3% ± 2.4% of cuspal interstitial cells were myofibroblasts expressing
-actin. In contrast, myofibroblasts comprised only 6.0% ± 1.1% of cells in late explants and 2.5% ± 0.4% and 4.6% ± 0.8% of cells in normal pulmonary and aortic valves, respectively (P < .05). In early autografts only 12.0% ± 4.6% of endothelial cells expressed the systemic arterial endothelial cell marker EphrinB2, whereas later explants had 85.6% ± 5.4% of endothelial cells expressing EphrinB2 (P < .05). In early autografts 43.8% ± 8.8% of interstitial cells expressed metalloproteinase 13, whereas late autografts had 11.4% ± 2.7% of interstitial cells expressing matrix metalloproteinase 13 (P < .05). Collagen content in autografts was comparable with that of normal valves and was higher than that seen in homograft valves (P < .005). However, autograft walls were damaged, with granulation tissue (early) and scarring, with focal loss of normal smooth muscle cells, elastin, and collagen (late).
CONCLUSIONS: The structure of pulmonary valves transplanted to the systemic circulation evolved toward that of normal aortic valves. Key processes in this remodeling included onset of a systemic endothelial cell phenotype and reversible plasticity of fibroblast-like valvular interstitial cells to myofibroblasts.
This article has been cited by other articles:
![]() |
L. de Kerchove, J. Rubay, A. Pasquet, A. Poncelet, C. Ovaert, M. Pirotte, M. Buche, W. D'Hoore, P. Noirhomme, and G. El Khoury Ross Operation in the Adult: Long-Term Outcomes After Root Replacement and Inclusion Techniques Ann. Thorac. Surg., January 1, 2009; 87(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Schoen Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering Circulation, October 28, 2008; 118(18): 1864 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chaput, M. D. Handschumacher, F. Tournoux, L. Hua, J. L. Guerrero, G. J. Vlahakes, and R. A. Levine Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation Circulation, August 19, 2008; 118(8): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carrel, M. Schwerzmann, F. Eckstein, T. Aymard, and A. Kadner Preliminary results following reinforcement of the pulmonary autograft to prevent dilatation after the Ross procedure. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 472 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Korff, J. Braun, D. Pfaff, H. G. Augustin, and M. Hecker Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment Blood, July 1, 2008; 112(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text] |
||||
![]() |
E. Aikawa, M. Nahrendorf, J.-L. Figueiredo, F. K. Swirski, T. Shtatland, R. H. Kohler, F. A. Jaffer, M. Aikawa, and R. Weissleder Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo Circulation, December 11, 2007; 116(24): 2841 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Pasquali, M. S. Cohen, D. Shera, G. Wernovsky, T. L. Spray, and B. S. Marino The Relationship Between Neo-Aortic Root Dilation, Insufficiency, and Reintervention Following the Ross Procedure in Infants, Children, and Young Adults J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1806 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aikawa, M. Nahrendorf, D. Sosnovik, V. M. Lok, F. A. Jaffer, M. Aikawa, and R. Weissleder Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease Circulation, January 23, 2007; 115(3): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Schoof, J. J.M. Takkenberg, R.-J. van Suylen, P. E. Zondervan, M. G. Hazekamp, R. A.E. Dion, and A. J.J.C. Bogers Degeneration of the pulmonary autograft: An explant study J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1426 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Sievers, T. Hanke, U. Stierle, M. F. Bechtel, B. Graf, D. R. Robinson, and D. N. Ross A Critical Reappraisal of the Ross Operation: Renaissance of the Subcoronary Implantation Technique? Circulation, July 4, 2006; 114(1_suppl): I-504 - I-511. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aikawa, P. Whittaker, M. Farber, K. Mendelson, R. F. Padera, M. Aikawa, and F. J. Schoen Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering Circulation, March 14, 2006; 113(10): 1344 - 1352. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |